Quality and Access Issues 28 th August 2012 UICC World Cancer - - PowerPoint PPT Presentation

Colorectal Screening

Quality and Access Issues

David Armstrong Division of Gastroenterology McMaster University Hamilton, Ontario, Canada

28th August 2012 UICC World Cancer Congress Montréal, Québec

Conflicts of Interest: David Armstrong “Quality and Access Issues”

Company Relationship Abbott Laboratories Consulting, Advisory, Speaking, Research Support, Educational Event AstraZeneca Canada Consulting, Advisory, Speaking, Research Support, Educational Event Axcan Pharma Speaking, Educational Event Sponsorship Boston Scientific Educational Event Sponsorship ConMed Canada Educational Event Sponsorship Cook Canada Educational Event Sponsorship Janssen Consulting, Advisory, Research Support, Educational Event Sponsorship Olympus Canada Advisory, Educational Event Sponsorship Pentax Medical Consulting, Advisory, Research Support, Educational Event Sponsorship Shire Canada Advisory, Educational Event Sponsorship Takeda Canada Consulting, Advisory, Speaking, Research Support, Educational Event Warner Chilcott\ Speaking, Research Support, Educational Event Sponsorship XenoPort Inc. Consulting, Advisory, Research Support

I shall not be discussing any unapproved or ‘off-label’ use of products

Colonoscopy Quality Overview

• Procedure vs Service delivery
• Attributes of colonoscopy
• Interdependence of quality and access
• Access to colonoscopy
• Key performance indicators
• Practice audit
• Framework to optimise colonoscopy

Colonoscopy Quality – The ‘Scope’

C–GRS

Preparation

Endoscopy Facility

Sedation Endoscopy Equipment Pathology Laboratory Nursing Referring MD Anesthesiologist Endoscopy Aide Management Diagnostic Imaging Information Technology

Colonoscopy

Procedure

Colonoscopy – Attributes

• Endoscopic examination of the large bowel &

distal small bowel (30 to 60 minutes)

• Diagnosis:

Visual, Biopsy

• Therapy:

Resection, Hemostasis, Dilation

• Colorectal cancer
• Diagnosis: Pre-neoplasia & Advanced neoplasia
• Therapy: Polypectomy, EMR, Hemostasis, Stenting
• Surveillance & Cancer Prevention (polypectomy)
• Diarrhea
• Rectal Bleeding
• Inflammatory Bowel Disease

Colonoscopy Quality – ‘Issues’

Quality Access

Impaired access impairs quality Reduced quality reduces access

Canadian Consensus on Wait Times for Digestive Health Care: Statements

• A. Patients referred because of a high likelihood of

cancer, based on imaging or physical examination, should be seen and, if indicated, endoscoped within two (2) weeks

• B. Patients referred with bright red rectal bleeding

should be seen and, if indicated, endoscoped within two (2) months

• C. Patients referred for screening colonoscopy

should be seen and, if indicated, endoscoped within six (6) months

Paterson WG et al. Can J Gastroenterol 2006;20(6):411-423

National Median Wait Times PAGE 4 – 2005

• Wait time: Referral to consultation
• 66 days [> 9 weeks]
• Wait time: Consultation to procedure
• 43 days [> 6 weeks]
• Total wait time: Referral to procedure
• 91 days [13 weeks]

Armstrong D et al. Can J Gastroenterol 2008;22:155

Colonoscopy – Wait Times – 2011

Estimated Numbers Awaiting Colonoscopy

9905$ 8223$ 18629$ 23116$ 38209$ 5472$

103552&

0$ 25'000$ 50'000$ 75'000$ 100'000$ BC$ AB$ Praire$ ON$ QC$ Atlan;c$ Total$

Pa)ent&Numbers&

Barua B et al. Waiting Your Turn. Fraser Institute 2011

GI Endoscopy – 2004-5 & 2008-9 Procedure volumes: Canada

406792$ 599175$ 154236$ 1160203$ 492888$ 969307$ 132701$ 1594896$ 0$ 500'000$ 1'000'000$ 1'500'000$ 2'000'000$ EGD$ Colonoscopy$ Sigmoidoscopy$ TOTAL$ 2004J2005$ 2008J2009$

+ 31.8% + 61.8%

Canadian Institutes for Health Information (CIHI) National Physician Database http://www.cihi.ca - Armstrong D & Khanna SS. Can J Gastroenterol 2012 (Abstract)

Colonoscopy – Appropriateness

EPAGE: European Panel of Appropriateness of Gastrointestinal Endoscopy

7.4$ 32.0$ 33.6$ 27.0$ 51.5$ 19.2$ 11.8$ 17.5$

0$ 25$ 50$ 75$ 100$ Necessary& Appropriate& Uncertain& Inappropriate&

Colonoscopies&(%)& EPAGE$I$ EPAGE$II$

Arguello L et al. Gastrointest Endosc 2012;75:138-145

60.5% (375/619) Not appropriate 29.3% (185/619) Not appropriate

Canadian Association of Gastroenterology Endoscopy Quality Consensus 2012

Armstrong D et al. Can J Gastroenterol 2012;26(1):17-31

Facility Standards and Policies

• Endoscopic procedures are performed for

an appropriate, clearly documented indication, consistent with current, evidence-based guidelines

• Explicit documentation of indication
• Evidence:

Low / Very Low

• Recommendation:

Do It – 97%

Armstrong D et al. Can J Gastroenterol 2012;26(1):17-31

Training, Education, Competency & Privileges

• Endoscopists should regularly review their

endoscopic practice and outcome data with the aim of continuous professional development

• Endoscopists’ ‘Report Card’ – Practice Audit
• Evidence:

Low / Very Low

• Recommendation:

Do It – 94%

Armstrong D et al. Can J Gastroenterol 2012;26(1):17-31

Practice Audit Program Principles

Data Analysis Point-of-Care Data Input Website Presentation Data Transmission Website Database Reflection

• n Practice

Data Review Change in Practice

QPE: Colonoscopy Practice Audit

• Quality & Safety Indicators Recorded

‘Key Performance Indicators’

• Wait times
• Indication (Reason)
• Time since last colonoscopy
• Patient age
• Procedure time (start, cecum, end)
• Preparation quality (Ottawa)
• Biopsy
• Polypectomy
• Immediate complications
• Sedation used

http://cag.medicalconsensus.org

Faigel DO, Cotton PB. OMED Endoscopy 2009;41:1069–1074

69 Physicians

CAG Colonoscopy Audit: 2008-2009

Polyp Removal vs. Withdrawal Time

20 40 60 80 100 0& 5& 10& 15& 20& 25& 30& Polyp&removal&(%&colonoscopies)& Mean&withdrawal&)me:&no&polyp&removal&(min)&

Polyp removal rate (%)

Spearman&Correla)on&Coefficient&=&0.3949& p&=&0.002&

Armstrong D et al. Can J Gastroenterol 2011;25:13-20

8 minutes 25% removal

Canadian Association of Gastroenterology Quality Program Structure

Quality Endoscopy

Endoscopy Global Rating Scale (GRS-C) Practice Audit Colonoscopy Endoscopy Residents Training Trainers Learners Practitioners Endoscopy Reporting Required Data Format Credentialing Maintain Current CAG Statements

Summary – 1

• Procedure quality should be addressed in

the context of system service delivery

• Colorectal screening is one of many

indications for colonoscopy

• Colonoscopy is a diagnostic and

therapeutic modality associated with potential for significant adverse events

• Quality and access issues for colonoscopy

are interdependent

Summary – 2

• Access to colonoscopy is limited despite

significant increases in procedural volumes

• Reductions in inappropriate procedures

may facilitate access to colonoscopy

• Consensus on key performance indicators

provides a basis for quality assurance

• Practice audit allows colonoscopists to

monitor and improve practice

• Quality & access issues can be addressed

within an overall quality framework